早期乳腺癌妇女术后服用三苯氧胺的时间至少5年是否是最佳方案？不同的研究人员通过两个独立的研究，得到的答案是肯定的。瑞典Rutqvist等发现，对于绝经后小于75岁、淋巴结阳性或阴性的早期乳腺癌患者，三苯氧胺辅助治疗5年者无瘤生存率和总生存率高于2年者，但这仅限于雌激素 Is early breast cancer women taking tamoxifen after surgery for at least 5 years the best option? Different researchers passed two separate studies and the answer was yes. Sweden’s Rutqvist et al. found that for early-stage breast cancer patients with postmenopausal age of less than 75 years, with positive or negative lymph nodes, tamoxifen-assisted 5-year disease-free survival and overall survival are higher than 2 years, but this is limited to estrogen